Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 32758030

Dabrafenib and Trametinib in Patients With Tumors With BRAF(V600E) Mutations: Results of the NCI-MATCH Trial Subprotocol H.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2020 Nov 20
First author
Salama AKS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Salama AKS
      type
      Author
    2. name
      Li S
      type
      Author
    3. name
      Macrae ER
      type
      Author
    4. name
      Park JI
      type
      Author
    5. name
      Mitchell EP
      type
      Author
    6. name
      Zwiebel JA
      type
      Author
    7. name
      Chen HX
      type
      Author
    8. name
      Gray RJ
      type
      Author
    9. name
      McShane LM
      type
      Author
    10. name
      Rubinstein LV
      type
      Author
    11. name
      Patton D
      type
      Author
    12. name
      Williams PM
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Salama AKS
      type
      Author
    2. name
      Li S
      type
      Author
    3. name
      Macrae ER
      type
      Author
    4. name
      Park JI
      type
      Author
    5. name
      Mitchell EP
      type
      Author
    6. name
      Zwiebel JA
      type
      Author
    7. name
      Chen HX
      type
      Author
    8. name
      Gray RJ
      type
      Author
    9. name
      McShane LM
      type
      Author
    10. name
      Rubinstein LV
      type
      Author
    11. name
      Patton D
      type
      Author
    12. name
      Williams PM
      type
      Author
    bibliography ids
    1. nci-bib-9ae87aefa425cfac277db0fa
    book metadata
    content sha256
    7592be4da148d975115f97947a6bc7515328457374f96588fb72c1e0c5566310
    document type
    citation
    dois
    1. 10.1200/JCO.20.00762
    electronic publication date
    display
    2020 Aug 6
    precision
    day
    year
    2020
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:32758030
    immutable id
    pubmed:32758030@7592be4da148d975115f97947a6bc7515328457374f96588fb72c1e0c5566310
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    33
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    3895-3904
    volume
    38
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      32758030
      provenance
      batch id
      40d9eae1f1d369f13109
      provider
      NCBI PubMed ESummary
      record sha256
      2ec48476dfa4b83bf255a0564ce87520f6393e4982b841703c69b32142785c88
      response sha256
      03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
      retrieved at
      2026-09-09T23:47:52.637547+00:00
      publication date
      display
      2020 Nov 20
      precision
      day
      year
      2020
      publication types
      1. Journal Article
      2. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/32758030/
      title
      Dabrafenib and Trametinib in Patients With Tumors With BRAF(V600E) Mutations: Results of the NCI-MATCH Trial Subprotocol H.

      Preserved source evidence · Independent clinical review pending · Not medical advice